A Canadian study is challenging the growing belief that previous infection with the Epstein-Barr virus (EBV) is necessary for multiple sclerosis (MS) to develop. The findings suggest the virus may not precede every MS case. Using public health insurance claims data, the researchers found a small group of people whose MS-related diagnostic claims appeared before […]
The post ACTRIMS 2026: New study questions whether EBV precedes every MS case appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com